Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
Illumina Names New Chief Executive
Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight with regulators. Source link
Amgen's Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
The Political Turf Battle Over the Future of Your Prime Rib
The White House must decide whether the Food and Drug Administration or Agriculture Department will oversee the food-company scientists tweaking genes to make animals heat
Biogen to Buy Reata in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Biogen to Cut Roughly 11% of Workforce
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
